Relapse is defined as a new TTP episode with thrombocytopenia, microangiopathic anemia, and low ADAMTS13 activity 30 days or more after treatment completion [106]. The gene discussed is ADAMTS13; the disease is thrombotic thrombocytopenic purpura.